SCV-07 (SciClone Pharmaceuticals/Verta).

Article Details

Citation
Copy to clipboard

Aspinall RJ, Pockros PJ

SCV-07 (SciClone Pharmaceuticals/Verta).

Curr Opin Investig Drugs. 2006 Feb;7(2):180-5.

PubMed ID
16499289 [ View in PubMed
]
Abstract

SciClone Pharmaceuticals and Verta are developing SCV-07, the lead in a series of immnunostimulants from Verta, for the potential treatment of tuberculosis and hepatitis C virus infection. Phase II clinical trials of the compound are ongoing.

DrugBank Data that Cites this Article

Drugs